Introduction
============

In 1999 the Japanese Orthopaedic Association (JOA) instituted a committee to establish a new standard of assessment that was based on patient-centered methods. The Japanese Society for Spine Surgery and Related Research and the Japanese Society of Lumbar Spine Disorders revised the criteria for cervical spinal myelopathy and lumbar spinal disorder, producing the JOA Cervical Myelopathy Evaluation Questionnaire (JOACMEQ) and the JOA Back Pain Evaluation Questionnaire in 2007 \[[@B1],[@B2],[@B3],[@B4]\]. We conducted a study to identify differences in postoperative time-dependent changes between the JOACMEQ and the JOA scores in patients with cervical spondylotic myelopathy (CSM) and in those with ossification of the posterior longitudinal ligament (OPLL) who underwent cervical laminoplasty.

Materials and Methods
=====================

This study was designed as prospective cohort study. Twenty-one patients enrolled in our study fulfilled the following criteria for inclusion: a clear history of progressive neurological deficiency due to cervical myelopathy, comparable radiography, magnetic resonance imaging, computed tomography findings verifying cervical stenosis at two or more levels, and acceptable cervical spine alignment without kyphotic deformity or radiological signs of instability. Patients with a history of cervical spine surgery or traumatic cervical lesions were excluded. Thirteen included subjects had CSM (the CSM group), and the other 8 had OPLL (the OPLL group). There were 9 males and 4 females in the CSM group, while all patients in the OPLL group were males. The average age at surgery was 65.2 years (range, 45-83 years) in the CSM group and 62.5 years (range, 46-70 years) in the OPLL group. All patients underwent a unilateral expansive open-door laminoplasty augmented with hydroxyapatite spacers. The decompression patterns in the CSM group were C3-C6 in 12 patients and C5-Th2 in 1 patient; on the other hand those in the OPLL group were C3-C6 in 3 patients, C3-C7 in 3 patients and C2-C6 in 2 patients. No restenosis due to hinge closure or major surgery-related complications were observed during at least 1 year of follow-up. We objectively evaluated the time-dependent changes in the patients\' JOACMEQ and JOA scores before surgery and at 2 weeks, 3 months, 6 months, and 1 year after cervical laminoplasty. JOACMEQ is a patient-based evaluation method for a cervical myelopathy comprising 24 questions. The answers are evaluated according to the calculation offered from five functional domains (cervical spine function, upper extremity function, lower extremity function, bladder function and quality of life). The following criteria were calculated on the basis of the user\'s guide for the JOACMEQ: the subscale points, the transition of the median value (minimum value minus maximum value), and the effectiveness rate at each evaluation point after surgery. The JOA score and Hirabayashi recovery rate were also evaluated at each point. We measured the correlation between each JOACMEQ subscale and the JOA score at each point using Spearman contingency coefficients.

Results
=======

[Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} showed the average total JOA scores and average Hirabayashi recovery rates, respectively, at multiple time points. The 2 groups had similar results, but the recovery rates were slightly better in the OPLL group than in the CSM group. The average total JOA score and the recovery rate improved significantly after surgery in both groups (*p*\<0.01). The median score for each JOACMEQ subscale was shown in [Figs. 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}. When each subscale point was compared pre- and post-surgery in patients with CSM, the cervical spine function improved significantly at 3 months post-surgery and the function of upper and lower extremities improved significantly at every postoperative evaluation point. Scores for quality of life improved only at 2 weeks and 3 months after surgery ([Fig. 3](#F3){ref-type="fig"}). The OPLL group showed no significant improvement in the function of the cervical spine, upper extremities, or bladder. Lower-extremity function and quality of life improved significantly only at 2 weeks after surgery ([Fig. 4](#F4){ref-type="fig"}). [Figs. 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"} showed the effectiveness rate for each JOACMEQ subscale in both groups. [Table 1](#T1){ref-type="table"} showed the Spearman contingency correlation coefficients between each JOACMEQ subscale and the JOA score in both groups. The coefficients were widely dispersed in both groups, except for upper- and lower-extremity function.

Discussion
==========

The current worldwide, standards for diagnosis of cervical spinal myelopathy are the Nurick scale \[[@B5]\] and the JOA score. Comparatively, the JOA score is the most useful, because the Nurick scale consists of only 6 simple grades. However, the JOA score is a physician-centered assessment tool created in 1975, which does not take into account patient satisfaction or quality of life. Both criteria are now considered important and are thus assessed by the JOACMEQ. Due to the emerging need to evaluate the impairments to patient activity in daily life, which is directly related to quality of life, various patient-oriented outcome measures, for example, the Short Form-36, have been developed and adopted by clinical practices in different medical fields. JOACMEQ was established to fulfill this need, as a self-rating questionnaire that could be filled out by patients themselves. Candidate questions included in the questionnaire were selected and modified from various preexisting outcome measures, including the Short Form-36, the Rolland and Morris Disability Questionnaire, and the Oswestry disability index. This questionnaire comprises 24 questions that were selected and validated through three large-scale studies. It designates the status of patients suffering cervical myelopathy from five different aspects, represented by five intuitive numerical scores. We found that the average JOA score was similar in both the CSM and OPLL groups. The transition of the average total JOA score before laminoplasty to that after laminoplasty have been documented elsewhere for patients with CSM and for those with OPLL:

Seichi et al. \[[@B6]\] reported scores of 8.3 before surgery and 11.4 at 1 year after surgery for patients with CSM, and scores of 8.6 and 12.4, respectively, for patients with OPLL (2001).Suda et al. \[[@B7]\] reported scores of 9.9 before surgery and 14.0 at 2 years after surgery for patients with CSM (2003).Higashino et al. \[[@B8]\] reported scores of 9.4 before surgery and 12.7 immediately after surgery for patients with CSM (2006). At the latest follow-up examination, the mean JOA score was 12.0.Yukawa et al. \[[@B9]\] reported scores of 11.1 before surgery and 14.0 at 6 months after surgery for patients with CSM (2007).Iwasaki et al. \[[@B10]\] reported scores of 9.0 before surgery and 14.1 at 3 years after surgery for patients with OPLL (2002).Ogawa et al. \[[@B11]\] reported scores of 9.2 before surgery and 14.2 at 3 years after surgery for patients with OPLL (2004).

The recovery rates in the studies for patients with CSM were as follows: Suda et al. \[[@B7]\], 60.2%; Higashino et al. \[[@B8]\], 43.4%; Yukawa et al. \[[@B9]\], 60.6%. The recovery rates for patients with OPLL were as follows: Iwasaki et al. \[[@B10]\], 63%; Ogawa et al. \[[@B11]\], 63.1%. The recovery rates in our study corroborated those from previous studies, with rates for the OPLL groups slightly better than rates for the CSM groups. However, we found that scores on the JOACMEQ subscale for cervical spine function improved gradually after surgery in the CSM group, while those in the OPLL group did not improve at all. The CSM group showed more improvement than the OPLL group in function of the upper and lower extremities, as assessed by the JOACMEQ. Generally, these results were already known from clinical experiments but could not be evaluated in detail using only conventional assessment. There was no significant improvement in bladder function at any point, as assessed by the JOACMEQ. Median scores for quality of life on the JOACMEQ improved significantly after surgery, but the rate for effectiveness of assessment was lower in both the CSM and the OPLL groups. Thus, reaching a consensus on the JOACMEQ effectiveness rate was difficult. For example, when looking at the upper- and lower-extremity function in the CSM group, we could judge that surgery was effective because the effectiveness rate was about 50% and the postoperative median score improved significantly compared with the preoperative score. Yet when looking at the quality of life, we could not determine whether surgery was effective, since the effectiveness rate was below 30%, despite significant improvement of the postoperative median score as compared to the preoperative score. As shown in [Table 1](#T1){ref-type="table"}, there was no consistent correlation between each JOACMEQ subscale and the JOA score. Therefore, we concluded that since both evaluation methods were quite different they are both needed until more widespread consensus on the interpretation of the JOACMEQ becomes available. There was a general correlation between JOA scores and scores on the JOACMEQ subscale for upper- and lower-extremity function, reflected by a lack of large distance between scores on the physician-centered tool (JOA) and those on the patient-centered tool (JOACMEQ). However, in the OPLL group, we found no obvious correlation between scores on the 2 assessment tools for either cervical spine function or quality of life; and in the CSM group, the correlation was low between scores on the 2 tools for cervical spine function. The new subscales of cervical spine function and quality of life were parameters that we could not assess with the JOA score. Most previous studies that assessed cervical spine function by evaluating the range of motion, degree of spinal curvature, or axial pain, did not provide adequate assessment with a patient-centered method. Agrawal et al. \[[@B12]\] recently reported assessment of quality of life using Odom\'s criteria. Chagas et al. \[[@B13]\] assessed quality of life with a 3-grade scale, Singh et al. \[[@B14]\] did so by the Short Form-36, and Kotani et al. \[[@B15]\] used the JOACMEQ subscale for quality of life. Despite all these prior assessments, no researcher had measured time-dependent postoperative changes affecting quality of life for patients with CSM or with OPLL. The salient feature of our study was the use of the JOACMEQ to assess cervical spine function and quality of life, parameters that cannot be assessed by the JOA scores. The JOACMEQ includes items assessed by the JOA score, but the JOACMEQ and the JOA score produce different findings because there is no consistent correlation between each JOACMEQ subscale and the JOA score. Hence both assessments should continue to be used until there is more consensual interpretation of the JOACMEQ. Our study had several limitations. Firstly, only 8 of the study subjects had OPLL. Secondly, the follow-up period was only 1 year. Thirdly, we could not easily implement our findings on the JOACMEQ because there was little consensus regarding the correspondence of its effectiveness rate to practical clinical relevance. The JOA score significantly corresponded to scores for the JOACMEQ subscales for upper- and lower-extremity function. However, for the OPLL group, the JOA score did not correlate with the JOACMEQ subscales for cervical spine function and quality of life. Moreover, in the CSM group, scores on the JOACMEQ cervical spine function subscale had little relation to JOA scores. These results indicated that the JOA score alone was not useful in assessing cervical spine function or quality of life.

Conclusions
===========

We reported time-dependent postoperative changes in the JOACMEQ and JOA scores in patients with CSM or OPLL who underwent cervical laminoplasty. Scores on subscales of the JOACMEQ for upper- and lower-extremity function correlated with JOA scores. The JOACMEQ can assess cervical spine function and quality of life, factors that cannot be assessed by the JOA score alone, hence the JOACMEQ is a more comprehensive modality of evaluation.
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JOACMEQ, Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire; JOA, Japanese Orthopaedic Association; CSM, cervical spondylotic myelopathy; OPLL, ossification of the posterior longitudinal ligament; W, weeks after surgery; M, months after surgery; Y, years after surgery.

^a)^Calculated using Spearman contingency coefficients.
